The contractor shall provide niaid with a broad and flexible range of capabilities that are required for preclinical and translational development support for promising vaccines and related products…
Active Awarded Last action
- Contract number
- 75N93022D00004
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $1,921,633 obligated
Award facts
- Opportunity
-
- Preclinical and translational vaccine development for HIV and other candidate agents Pre-Solicitation · 75N93019R00023 · Posted Mar 26, 2020
- Combined order value
- $3,785,038 Current and potential, with all options
- Last date to order 70% complete
- IDV ceiling 1% used
- $364,553,934.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases (NIAID) awarded an indefinite-delivery contract to Advanced Bioscience Laboratories, Inc. with a ceiling of $364,553,934 on December 1, 2021, as one of multiple awards under the Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents program. No set-aside applies to this vehicle.
Place of performance is Rockville, Maryland. The IDIQ supports NIAID's development of preclinical and translational capabilities for promising HIV vaccines and related products for other candidate agents, including product storage and shipping, safety and immunogenicity studies, feasibility assessments, analytical development, process development, cGMP manufacturing, stability testing, fill-finish operations, and scientific and quality support. The contract runs from June 2021 through June 2028 with optional extensions. NAICS code 541715 (research and development in biotechnology) applies; the size standard is 1,000 employees.
The solicitation anticipated approximately 15 to 20 task orders annually, ranging from $98 million to $318 million over the seven-year performance period. Task Area G for scientific, quality, and regulatory support services was set aside for small business concerns only; all other task areas were open to all qualified contractors.
Two delivery orders have been issued under this vehicle: a $2,500 cost-no-fee order awarded December 1, 2021 to fund the guaranteed minimum amount, with performance through November 30, 2022; and a $3,782,538 cost-plus-fixed-fee delivery order awarded August 31, 2024 for feasibility studies on developing a liposome/lipid nanoparticle displaying an HIV envelope trimer protein and incorporating messenger RNA, with completion targeted for August 27, 2028.
Description
The contractor shall provide niaid with a broad and flexible range of capabilities that are required for preclinical and translational development support for promising vaccines and related products for HIV and other candidate agents.the contractor s
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93022D00004?
75N93022D00004 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 1, 2021.
How much is contract 75N93022D00004 worth?
Orders under 75N93022D00004 have obligated $1,921,633. Their combined current value, with exercised options, is $3,785,038. 75N93022D00004's own ceiling is $364,553,934.
How many orders have been placed under contract 75N93022D00004?
2 orders have been placed under 75N93022D00004, the latest on August 31, 2024.
Who can order from contract 75N93022D00004?
75N93022D00004 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93022D00004 part of a contract vehicle?
Yes. 75N93022D00004 is part of Preclinical And Translational Vaccine Development For HIV And Other Candidate Agents.
Was contract 75N93022D00004 competed?
The extent of competition for 75N93022D00004 was full and open competition. The government received 9 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV